Literature DB >> 16710040

Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer.

Daniel Ajzensztejn1, Vinayak S Hegde, Siow Ming Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710040     DOI: 10.1200/JCO.2005.02.8753

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA).

Authors:  Ke-Qing Qian; Heng Ye; Yi-Wen Xiao; Yong-Yi Bao; Chun-Jian Qi
Journal:  Int J Gen Med       Date:  2009-07-30

Review 2.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

3.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

4.  Tumor lysis without syndrome in adenocarcinoma of the lung: Case report.

Authors:  Amit Chopra; Creticus Marak; Narendra Kumar Alappan; Daniel Alterman; Chang Shim
Journal:  Respir Med Case Rep       Date:  2013-09-07

5.  Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer.

Authors:  Tomomichi Ito; Tsuyoshi Ohta; Megumi Narumi; Hirotsugu Sakaki; Manabu Seino; Takeshi Sudo; Satoru Nagase
Journal:  Gynecol Oncol Rep       Date:  2018-02-24

Review 6.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.